Abstract
Get full access to this article
View all access options for this article.
References
1.
Prasad
V
,
Makary
MA
One pivotal trial, the new default option for FDA approval—Ending the two-trial dogma . N Engl J Med , 2026 ; 394 (8 ):815 –817 .